Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial
JAMA : the journal of the American Medical Association, 2012-12, Vol.308 (22), p.2369 [Peer Reviewed Journal]EISSN: 1538-3598 ;DOI: 10.1001/jama.2012.25321 ;PMID: 23117550
Digital Resources/Online E-Resources